相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
Jason Gotlib et al.
NATURE MEDICINE (2021)
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis
Georg Greiner et al.
HAEMATOLOGICA (2020)
Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia
Adil S. A. Al Hinai et al.
LEUKEMIA (2020)
Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis
Jeffrey W. Craig et al.
MODERN PATHOLOGY (2020)
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis
Jennine Grootens et al.
EBIOMEDICINE (2019)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis
M. Arock et al.
LEUKEMIA (2015)
Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia
Thomas Kristensen et al.
LEUKEMIA & LYMPHOMA (2012)
Systemic mastocytosis associated with t(8;21) acute myeloid leukemia in a child: Detection of the D816A mutation of KIT
Miharu Yabe et al.
PEDIATRIC BLOOD & CANCER (2012)
Mutation D816V Alters the Internal Structure and Dynamics of c-KIT Receptor Cytoplasmic Region: Implications for Dimerization and Activation Mechanisms
Elodie Laine et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia
Surnimasa Nagai et al.
EXPERIMENTAL HEMATOLOGY (2007)
Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone
Vinod Pullarkat et al.
LEUKEMIA RESEARCH (2007)
Systemic mastocytosis associated with acute myeloid leukemia:: Case report and implications for disease pathogenesis
L Escribano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge
HP Horny et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
CD25 indicates the neoplastic phenotype of mast cells - A novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens
K Sotlar et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
分享论文
